Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Dimerix Limited
  6. Company
    DXB   AU000000DXB7

DIMERIX LIMITED

(DXB)
SummaryChartsNewsCalendarCompanyFinancials 
Business Summary
Dimerix Limited is an Australia-based biopharmaceutical company. The Company is engaged in the development of new therapies in areas with unmet medical need. The Company is developing four product indications: Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19, diabetic kidney disease, and DMX-700 for Chronic Obstructive Pulmonary Disease (COPD), as well as the its Receptor-HIT assay technology. The CompanyÔÇÖs pipeline products include DMX-200, DMX-700 and DMX-XXX. DMX-200, which is developed for FSGS, COVID-19 pneumonia patient in ICU and respiratory complications in COVID-19 patients is under Phase III clinical trial. DMX-200, which is developed for diabetic kidney disease is under Phase II clinical trial. DMX-700, which is developed for COPD is under Phase I clinical trial. DMX-XXX is under Phase I clinical trial.
Managers
Name Title Age Since
Nina Webster, Dr. Chief Executive Officer, MD & Director - 2018
Hamish George Chief Financial Officer & Secretary - 2019
David Packham, Dr. Chief Medical Officer - 2018
Robert Shepherd Director-Research & Development - -
Sonia Maria Poli, Dr. Independent Non-Executive Director 55 2015
Members of the board
Name Title Age Since
James Howard Williams, Dr. Non-Executive Chairman 50 2017
Sonia Maria Poli, Dr. Independent Non-Executive Director 55 2015
Hugh Alsop Non-Executive Director - 2017
Nina Webster, Dr. Chief Executive Officer, MD & Director - 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 197,999,297 181,170,590 91.5% 0 0.0% 91.5%
Shareholders
NameEquities%
Peter Fletcher Meurs 44,179,309 13.8%
Merchant Funds Management Pty Ltd. 17,925,000 5.59%
Company contact information
Dimerix Ltd.
425 Smith Street
Fitzroy 3065
Melbourne, Victoria (VIC) 3065

Web : http://www.dimerix.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Dimerix Limited
Sector Other Biotechnology & Medical Research